2:00pm |
6:00pm |
Eastlake Building/E1-101 |
AHEAD |
|
Start |
End |
Building/Room |
Title / Topic |
7:00am |
8:00am |
Weintraub/ Lobby |
Registration |
N/A |
N/A |
8:00am |
8:15am |
Weintraub/Pelton |
Welcome / Fred Hutch Representative |
Garnet Anderson, PhD, Senior Vice President and Director, Public Health Sciences |
01 |
8:15am |
8:45am |
Weintraub/Pelton |
State of the EDRN: 25th Anniversary |
Sudhir Srivastava, PhD, MPH, Senior Scientific Officer & Chief, Cancer Biomarkers Research Group, NCI |
02 |
8:45am |
9:00am |
Transition to Collaborative Group Locations |
9:00am |
1:00pm |
See Below |
Collaborative Group Meetings |
See separate agendas |
N/A |
|
|
Yale/J2-515 |
• BGYN Collaborative Group |
See separate agenda |
N/A |
|
|
Eastlake E3-160 |
• GI Collaborative Group |
See separate agenda |
N/A |
|
|
Eastlake E1-101 |
• GU Collaborative Group |
See separate agenda |
N/A |
|
|
Weintraub/ Pelton |
• Lung/AHEAD Collaborative Group |
See separate agenda |
N/A |
1:00pm |
2:30pm |
On Own |
Lunch & Networking |
N/A |
N/A |
2:30pm |
6:00pm |
Weintraub/ Pelton |
CVC Session 1 Presentations – include BCC and Industry partners |
N/A |
2:30pm |
2:50pm Q&A (5m) |
Weintraub/ Pelton |
CVC Breast Group 1 |
- Chris Li, MD, PhD, Fred Hutchinson Cancer Center
- Savannah Partridge PhD, University of Washington
|
03 |
2:50pm |
3:10pm Q&A (5m) |
Weintraub/ Pelton |
EDRN Clinical Validation Center on Pancreatic Cancer Gulf Coast-Great Lakes-East Coast (GCGLEC) CVC (U01CA200468) |
- Anirban Maitra, MBBS, New York University Langone Health
|
04 |
3:10pm |
3:30pm Q&A (5m) |
Weintraub/ Pelton |
CVC Pancreas Group 2 |
- Randall Brand, MD, University of Pittsburgh
- Surinder Batra, PhD, University of Nebraska Medical Center
|
05 |
3:30pm |
3:50pm Q&A (5m) |
Weintraub/ Pelton |
CVC Esophagus Group 1: Biomarker Based Interception of Esophageal Adenocarcinoma |
- Sanford Markowitz, MD, PhD, Case Western Reserve University
- Chetan Bettegowda, MD, PhD, Johns Hopkins University
- Amitabh Chak, MD, UH Cleveland Medical Center
- Nicholas Shaheen, MD, MPH, BA, University of North Carolina
- Sachin Wani, MD, University of Colorado Anschutz Medical Campus
- Joseph Willis, MD, Case Western Reserve University
|
06 |
3:50pm |
4:05pm |
|
Break |
|
|
4:05pm |
4:25pm Q&A (5m) |
Weintraub/ Pelton |
CVC Head and Neck Group 1 |
- Karen Anderson, MD, PhD, Arizona State University
- Erich Sturgis, MD, MPH, Baylor College of Medicine
|
07 |
4:25pm |
4:45pm Q&A (5m) |
Weintraub/ Pelton |
CVC Breast and Lung Imaging Group 1 |
- John Heine, PhD, H. Lee Moffitt Cancer Center & Research Institute Inc.
- Matthew Schabath, PhD, H. Lee Moffitt Cancer Center & Research Institute Inc.
|
08 |
4:45pm |
5:00pm |
|
Break |
|
|
5:00pm |
5:20pm Q&A (5m) |
Weintraub/ Pelton |
CVC Lung Group 1 |
- Eric Grogan, MD, Vanderbilt-Ingram Cancer Center
- Stephen Deppen, PhD, Vanderbilt University Medical Center
|
09 |
5:20pm |
5:40pm Q&A (5m) |
Weintraub/ Pelton |
CVC Lung Group 2 |
- Samir Hanash, MD, PhD, The University of Texas MD Anderson Cancer Center
|
10 |
5:40pm |
6:00pm Q&A (5m) |
Weintraub/ Pelton |
CVC Lung Group 3 |
- Victor Velculescu, MD, PhD, Johns Hopkins University
- David Sidransky, MD, Johns Hopkins University
|
11 |
6:00pm |
6:00pm |
Weintraub/ Pelton |
Adjourn |
Start |
End |
Building/Room |
Title / Topic |
7:00am |
8:00am |
Weintraub/ Lobby |
Registration |
N/A |
N/A |
8:00am |
8:25am Q&A (5m) |
Weintraub/ Pelton |
Keynote Speaker 1 Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality from Colorectal Cancer A Pragmatic, Randomized, Comparative-Effectiveness Study |
- Jason Dominitz, MD, Executive Director, US Department of Veterans Affairs National Gastroenterology & Hepatology Program and Professor of Medicine, Gastroenterology Division, University of Washington
|
12 |
8:25am |
8:50am Q&A (5m) |
Weintraub/ Pelton |
Keynote Speaker 2 |
- Carolyn Rutter, PhD, Professor, Biostatistics Program & Hutchinson Institute for Outcomes Research (HICOR), Public Health Sciences Division, Fred Hutchinson Cancer Center
|
13 |
8:50am |
9:10am Q&A (5m) |
Weintraub/ Pelton |
Summary of the Workshop & Discussion |
- James Willey MD, University of Toledo
- Cecilia Yeung MD, Fred Hutchinson Cancer Center
|
14 |
9:10am |
9:30am Q&A (5m) |
Weintraub/ Pelton |
Move AHEAD for the Earliest Detection of Oral Cancer |
- Yu Leo Lei, PhD, DDS, The University of Texas MD Anderson Cancer Center
|
15 |
9:30am |
9:50am Q&A (5m) |
Weintraub/ Pelton |
Breast and Gynecological Cancers CG Summary |
- Savannah Partridge, PhD, University of Washington
- Abhijit Patel, MD, Yale University
|
16 |
9:50am |
10:05am |
|
Break |
|
|
10:05am |
10:25am Q&A (5m) |
Weintraub/ Pelton |
Lung Cancer CG Summary |
- Eric Grogan, MD, Vanderbilt-Ingram Cancer Center
- Sara Pai, MD, PhD, Yale University
|
17 |
10:25am |
10:45am Q&A (5m) |
Weintraub/ Pelton |
Prostate and Urologic Cancers CG Summary |
- Jeffrey Tosoian, MD, Vanderbilt University Medical Center
- John Semmes, PhD, Eastern Virginia Medical School
|
18 |
10:45am |
11:05am Q&A (5m) |
Weintraub/ Pelton |
GI Collaborative Group |
- Bob Bresalier, MD, The University of Texas MD Anderson Cancer Center
|
19 |
11:05am |
11:35am Q&A (5m) |
Weintraub/ Pelton |
General Remarks and Open Discussion with EDRN Steering Committee Members |
- Arul Chinnaiyan, MD, PhD, University of Michigan
- Karen Anderson, MD, PhD, Arizona State University
|
N/A |
11:35am |
12:00pm |
Undedicated Time |
12:00pm |
2:00pm |
On Own |
Lunch |
12:00pm |
2:00pm |
Arnold/E3-160 |
Executive Committee / NCT (virtual component) – Arul Chinnaiyan on EDRN accomplishments – 10 min + 5 min Questions and Discussion; CG/AHEAD highlights-7 min each followed by 5 min Questions and Discussion, 45 min Open Discussion with NCT members |
- Closed Session
- EDRN Chair: Overview, State, and Future of EDRN (10 min/5 min Q&A)
- CG Presentations to the NCT (7 min/5 min Q&A)
- Accomplishments and Future Plans
- Discussion (45 min)
|
N/A |
2:00pm |
2:20pm Q&A (5m) |
Weintraub/ Pelton |
CVC Prostate Group 1 |
- Martin Sanda, MD, Emory University
|
20 |
2:20pm |
2:40pm Q&A (5m) |
Weintraub/ Pelton |
CVC Ovary Group 1 |
- Robert Bast, MD, The University of Texas MD Anderson Cancer Center
|
21 |
2:40pm |
3:00pm Q&A (5m) |
Weintraub/ Pelton |
Great Lakes-New England (GLNE) Clinical Validation Center Update |
- Bob Bresalier, MD, The University of Texas MD Anderson Cancer Center
- Sapna Syngal, MD, Dana Farber Cancer Institute
|
22 |
3:00pm |
3:20pm Q&A (5m) |
Weintraub/ Pelton |
CVC Colon Group 2 |
- Robert Schoen, MD, PhD, University of Pittsburgh Cancer Institute
- Cristian Tomasetti, PhD, City of Hope/TGen
|
23 |
3:20pm |
3:35pm |
|
Break |
|
|
3:35pm |
3:55pm Q&A (5m) |
Weintraub/ Pelton |
Liver Clinical Validation Center |
- Neehar Parikh, MD, University of Michigan
- Fasiha Kanwal, MD, Baylor College of Medicine
- Jorge Marrero, MD, MS, University of Pennsylvania
|
24 |
3:55pm |
5:15pm |
Weintraub/ Pelton |
Clinical Utility Trial & Validation Study Updates |
N/A |
3:55pm |
4:25pm Q&A (5m) |
Weintraub/ Pelton |
National Liver Cancer Screening (TRACER) Trial |
- Neehar Parikh, MD, University of Michigan
|
25 |
4:25pm |
4:50pm Q&A (5m) |
Weintraub/ Pelton |
NCI EARLY DETECTION RESEARCH NETWORK PROSTATE MRI BIOMARKER STUDY AND REFERENCE SET (PMRI): PHASE 2 |
- John T. Wei, MD, MS, University of Michigan
|
26 |
4:50pm |
5:15pm Q&A (5m) |
Weintraub/ Pelton |
APaCC |
- Eugene Koay, MD, PhD, The University of Texas MD Anderson Cancer Center
|
27 |
5:15pm |
5:40pm Q&A (5m) |
Weintraub/ Pelton |
Informatics |
- Dan Crichton, MS, NASA Jet Propulsion Laboratory
|
28 |
5:40pm |
6:00pm Q&A (5m) |
Weintraub/ Pelton |
NCI’s Early Detection Research Network Clinical Biospecimen Reference Sets - Resource for Community |
- Indu Kohaar, PhD, National Cancer Institute
|
29 |
6:00pm |
6:00pm |
Weintraub/ Pelton |
ADJOURN |
Start |
End |
Building/Room |
Title / Topic |
7:00am |
8:00am |
Arnold/Behnke M1-A303/305/307 |
Registration |
N/A |
N/A |
8:00am |
9:00am |
Arnold/Behnke M1-A303/305/307 |
Open Discussion – Team Projects across EDRN to form the basis for potential proposals to CSRN for an ancillary study |
Karen Anderson, MD, PhD, Arizona State University |
N/A |
9:00am |
9:45am |
Arnold/Behnke M1-A303/305/307 |
Updates from EDRN Investigators on Markers Reaching Phase 2 and 3 |
N/A |
N/A |
9:45am |
10:30am |
Arnold/Behnke M1-A303/305/307 |
Moving Forward with Phase 3 Biomarkers: Intended Goals and Plans |
N/A |
N/A |
10:30am |
10:30am |
Arnold/Behnke M1-A303/305/307 |
ADJOURN Steering Committee Meeting |
N/A |
N/A |
11:00am |
1:00pm |
Eastlake/E1-101 |
EDRN EC/NCI/CSRN (Closed Session) |